Empiric Therapy With Moxalactam Alone in Patients With Bacteremia
- 1 May 1984
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 59 (5), 318-326
- https://doi.org/10.1016/s0025-6196(12)61427-x
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- The Clinical Significance of Positive Blood Cultures: A Comprehensive Analysis of 500 Episodes of Bacteremia and Fungemia in Adults. II. Clinical Observations, with Special Reference to Factors Influencing PrognosisClinical Infectious Diseases, 1983
- Moxalactam in the therapy of serious infectionsAntimicrobial Agents and Chemotherapy, 1982
- Clinical evaluation of moxalactamAntimicrobial Agents and Chemotherapy, 1981
- Therapy of lower respiratory tract infections with moxalactamAntimicrobial Agents and Chemotherapy, 1981
- Moxalactam therapy for a wide spectrum of bacterial infections in adultsAntimicrobial Agents and Chemotherapy, 1981
- Moxalactam and cefazolin: comparative pharmacokinetics in normal subjectsAntimicrobial Agents and Chemotherapy, 1981
- Therapy of obstetrical infections with moxalactamAntimicrobial Agents and Chemotherapy, 1980
- Gram-negative bacteremiaThe American Journal of Medicine, 1980
- Polymicrobial BacteremiaAnnals of Internal Medicine, 1970
- INFECTIONS DUE TO GRAM-NEGATIVE ORGANISMS: AN ANALYSIS OF 860 PATIENTS WITH BACTEREMIA AT THE UNIVERSITY OF MINNESOTA MEDICAL CENTER, 1958–1966Medicine, 1969